Genetic Modification of Huntington Disease Acts Early in the Prediagnosis Phase

Jeffrey D. Long, Jong Min Lee, Elizabeth H. Aylward, Tammy Gillis, Jayalakshmi Srinidhi Mysore, Kawther Abu Elneel, Michael J. Chao, Jane S. Paulsen, Marcy E. MacDonald, James F. Gusella

Research output: Contribution to journalArticle

Abstract

Age at onset of Huntington disease, an inherited neurodegenerative disorder, is influenced by the size of the disease-causing CAG trinucleotide repeat expansion in HTT and by genetic modifier loci on chromosomes 8 and 15. Stratifying by modifier genotype, we have examined putamen volume, total motor score (TMS), and symbol digit modalities test (SDMT) scores, both at study entry and longitudinally, in normal controls and CAG-expansion carriers who were enrolled prior to the emergence of manifest HD in the PREDICT-HD study. The modifiers, which included onset-hastening and onset-delaying alleles on chromosome 15 and an onset-hastening allele on chromosome 8, revealed no major effect in controls but distinct patterns of modification in prediagnosis HD subjects. Putamen volume at study entry showed evidence of reciprocal modification by the chromosome 15 alleles, but the rate of loss of putamen volume was modified only by the deleterious chromosome 15 allele. By contrast, both alleles modified the rate of change of the SDMT score, but neither had an effect on the TMS. The influence of the chromosome 8 modifier was evident only in the rate of TMS increase. The data indicate that (1) modification of pathogenesis can occur early in the prediagnosis phase, (2) the modifier loci act in genetic interaction with the HD mutation rather than through independent additive effects, and (3) HD subclinical phenotypes are differentially influenced by each modifier, implying distinct effects in different cells or tissues. Together, these findings indicate the potential benefit of using genetic modifier strategies for dissecting the prediagnosis pathogenic process in HD.

Original languageEnglish (US)
Pages (from-to)349-357
Number of pages9
JournalAmerican Journal of Human Genetics
Volume103
Issue number3
DOIs
StatePublished - Sep 6 2018
Externally publishedYes

Fingerprint

Huntington Disease
Chromosomes, Human, Pair 15
Chromosomes, Human, Pair 8
Alleles
Putamen
Trinucleotide Repeat Expansion
Genetic Loci
Age of Onset
Neurodegenerative Diseases
Genotype
Phenotype
Mutation

Keywords

  • age at onset
  • CAG expansion
  • FAN1
  • genetic modifier
  • HTT
  • Huntington disease
  • RRM2B
  • symbol digits modalities test
  • total motor score
  • trinucleotide repeat

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Long, J. D., Lee, J. M., Aylward, E. H., Gillis, T., Mysore, J. S., Abu Elneel, K., ... Gusella, J. F. (2018). Genetic Modification of Huntington Disease Acts Early in the Prediagnosis Phase. American Journal of Human Genetics, 103(3), 349-357. https://doi.org/10.1016/j.ajhg.2018.07.017

Genetic Modification of Huntington Disease Acts Early in the Prediagnosis Phase. / Long, Jeffrey D.; Lee, Jong Min; Aylward, Elizabeth H.; Gillis, Tammy; Mysore, Jayalakshmi Srinidhi; Abu Elneel, Kawther; Chao, Michael J.; Paulsen, Jane S.; MacDonald, Marcy E.; Gusella, James F.

In: American Journal of Human Genetics, Vol. 103, No. 3, 06.09.2018, p. 349-357.

Research output: Contribution to journalArticle

Long, JD, Lee, JM, Aylward, EH, Gillis, T, Mysore, JS, Abu Elneel, K, Chao, MJ, Paulsen, JS, MacDonald, ME & Gusella, JF 2018, 'Genetic Modification of Huntington Disease Acts Early in the Prediagnosis Phase', American Journal of Human Genetics, vol. 103, no. 3, pp. 349-357. https://doi.org/10.1016/j.ajhg.2018.07.017
Long, Jeffrey D. ; Lee, Jong Min ; Aylward, Elizabeth H. ; Gillis, Tammy ; Mysore, Jayalakshmi Srinidhi ; Abu Elneel, Kawther ; Chao, Michael J. ; Paulsen, Jane S. ; MacDonald, Marcy E. ; Gusella, James F. / Genetic Modification of Huntington Disease Acts Early in the Prediagnosis Phase. In: American Journal of Human Genetics. 2018 ; Vol. 103, No. 3. pp. 349-357.
@article{24a5b0cf1a7a4dfd90fff549893a30bd,
title = "Genetic Modification of Huntington Disease Acts Early in the Prediagnosis Phase",
abstract = "Age at onset of Huntington disease, an inherited neurodegenerative disorder, is influenced by the size of the disease-causing CAG trinucleotide repeat expansion in HTT and by genetic modifier loci on chromosomes 8 and 15. Stratifying by modifier genotype, we have examined putamen volume, total motor score (TMS), and symbol digit modalities test (SDMT) scores, both at study entry and longitudinally, in normal controls and CAG-expansion carriers who were enrolled prior to the emergence of manifest HD in the PREDICT-HD study. The modifiers, which included onset-hastening and onset-delaying alleles on chromosome 15 and an onset-hastening allele on chromosome 8, revealed no major effect in controls but distinct patterns of modification in prediagnosis HD subjects. Putamen volume at study entry showed evidence of reciprocal modification by the chromosome 15 alleles, but the rate of loss of putamen volume was modified only by the deleterious chromosome 15 allele. By contrast, both alleles modified the rate of change of the SDMT score, but neither had an effect on the TMS. The influence of the chromosome 8 modifier was evident only in the rate of TMS increase. The data indicate that (1) modification of pathogenesis can occur early in the prediagnosis phase, (2) the modifier loci act in genetic interaction with the HD mutation rather than through independent additive effects, and (3) HD subclinical phenotypes are differentially influenced by each modifier, implying distinct effects in different cells or tissues. Together, these findings indicate the potential benefit of using genetic modifier strategies for dissecting the prediagnosis pathogenic process in HD.",
keywords = "age at onset, CAG expansion, FAN1, genetic modifier, HTT, Huntington disease, RRM2B, symbol digits modalities test, total motor score, trinucleotide repeat",
author = "Long, {Jeffrey D.} and Lee, {Jong Min} and Aylward, {Elizabeth H.} and Tammy Gillis and Mysore, {Jayalakshmi Srinidhi} and {Abu Elneel}, Kawther and Chao, {Michael J.} and Paulsen, {Jane S.} and MacDonald, {Marcy E.} and Gusella, {James F.}",
year = "2018",
month = "9",
day = "6",
doi = "10.1016/j.ajhg.2018.07.017",
language = "English (US)",
volume = "103",
pages = "349--357",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - Genetic Modification of Huntington Disease Acts Early in the Prediagnosis Phase

AU - Long, Jeffrey D.

AU - Lee, Jong Min

AU - Aylward, Elizabeth H.

AU - Gillis, Tammy

AU - Mysore, Jayalakshmi Srinidhi

AU - Abu Elneel, Kawther

AU - Chao, Michael J.

AU - Paulsen, Jane S.

AU - MacDonald, Marcy E.

AU - Gusella, James F.

PY - 2018/9/6

Y1 - 2018/9/6

N2 - Age at onset of Huntington disease, an inherited neurodegenerative disorder, is influenced by the size of the disease-causing CAG trinucleotide repeat expansion in HTT and by genetic modifier loci on chromosomes 8 and 15. Stratifying by modifier genotype, we have examined putamen volume, total motor score (TMS), and symbol digit modalities test (SDMT) scores, both at study entry and longitudinally, in normal controls and CAG-expansion carriers who were enrolled prior to the emergence of manifest HD in the PREDICT-HD study. The modifiers, which included onset-hastening and onset-delaying alleles on chromosome 15 and an onset-hastening allele on chromosome 8, revealed no major effect in controls but distinct patterns of modification in prediagnosis HD subjects. Putamen volume at study entry showed evidence of reciprocal modification by the chromosome 15 alleles, but the rate of loss of putamen volume was modified only by the deleterious chromosome 15 allele. By contrast, both alleles modified the rate of change of the SDMT score, but neither had an effect on the TMS. The influence of the chromosome 8 modifier was evident only in the rate of TMS increase. The data indicate that (1) modification of pathogenesis can occur early in the prediagnosis phase, (2) the modifier loci act in genetic interaction with the HD mutation rather than through independent additive effects, and (3) HD subclinical phenotypes are differentially influenced by each modifier, implying distinct effects in different cells or tissues. Together, these findings indicate the potential benefit of using genetic modifier strategies for dissecting the prediagnosis pathogenic process in HD.

AB - Age at onset of Huntington disease, an inherited neurodegenerative disorder, is influenced by the size of the disease-causing CAG trinucleotide repeat expansion in HTT and by genetic modifier loci on chromosomes 8 and 15. Stratifying by modifier genotype, we have examined putamen volume, total motor score (TMS), and symbol digit modalities test (SDMT) scores, both at study entry and longitudinally, in normal controls and CAG-expansion carriers who were enrolled prior to the emergence of manifest HD in the PREDICT-HD study. The modifiers, which included onset-hastening and onset-delaying alleles on chromosome 15 and an onset-hastening allele on chromosome 8, revealed no major effect in controls but distinct patterns of modification in prediagnosis HD subjects. Putamen volume at study entry showed evidence of reciprocal modification by the chromosome 15 alleles, but the rate of loss of putamen volume was modified only by the deleterious chromosome 15 allele. By contrast, both alleles modified the rate of change of the SDMT score, but neither had an effect on the TMS. The influence of the chromosome 8 modifier was evident only in the rate of TMS increase. The data indicate that (1) modification of pathogenesis can occur early in the prediagnosis phase, (2) the modifier loci act in genetic interaction with the HD mutation rather than through independent additive effects, and (3) HD subclinical phenotypes are differentially influenced by each modifier, implying distinct effects in different cells or tissues. Together, these findings indicate the potential benefit of using genetic modifier strategies for dissecting the prediagnosis pathogenic process in HD.

KW - age at onset

KW - CAG expansion

KW - FAN1

KW - genetic modifier

KW - HTT

KW - Huntington disease

KW - RRM2B

KW - symbol digits modalities test

KW - total motor score

KW - trinucleotide repeat

UR - http://www.scopus.com/inward/record.url?scp=85056392438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056392438&partnerID=8YFLogxK

U2 - 10.1016/j.ajhg.2018.07.017

DO - 10.1016/j.ajhg.2018.07.017

M3 - Article

C2 - 30122542

AN - SCOPUS:85056392438

VL - 103

SP - 349

EP - 357

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 3

ER -